Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Edesa Biotech Inc | EDSA | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
4.5141 |
Trades | Shares Traded | Average Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 2.4603 - 8.3331 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
- | 0 | US$ 4.5141 | USD |
Edesa Biotech Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
US$ 14.32M | - | - | - | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Edesa Biotech News
Date | Time | Source | News Article |
---|---|---|---|
3/01/2024 | 17:20 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
2/09/2024 | 15:46 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
2/09/2024 | 15:20 | Edgar (US Regulatory) | Form 8-K - Current report |
2/02/2024 | 20:30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
1/29/2024 | 15:29 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
1/16/2024 | 16:03 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of.. |
1/12/2024 | 16:30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
12/15/2023 | 15:44 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
12/15/2023 | 15:17 | Edgar (US Regulatory) | Form 8-K - Current report |
10/26/2023 | 07:01 | Edgar (US Regulatory) | Form 8-K - Current report |
10/23/2023 | 06:58 | Edgar (US Regulatory) | Form 8-K - Current report |
10/12/2023 | 11:22 | Edgar (US Regulatory) | Form 8-K - Current report |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical EDSA Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 4.65 | 4.80 | 4.12 | 4.54 | 3,797 | -0.1359 | -2.92% |
1 Month | 4.48 | 4.88 | 4.12 | 4.42 | 3,326 | 0.0341 | 0.76% |
3 Months | 5.52 | 5.6243 | 3.88 | 4.56 | 8,209 | -1.01 | -18.22% |
6 Months | 3.02 | 6.46 | 2.50 | 4.54 | 19,612 | 1.49 | 49.47% |
1 Year | 6.7921 | 8.3331 | 2.4603 | 4.99 | 58,702 | -2.28 | -33.54% |
3 Years | 44.59 | 84.00 | 2.4603 | 58.62 | 389,848 | -40.08 | -89.88% |
5 Years | 36.05 | 133.70 | 2.4603 | 54.06 | 408,493 | -31.54 | -87.48% |
Edesa Biotech Description
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side-effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients. |